Physician profile
Margaret Mitchell
NPI 1861711921
$1,730.15
in general payments reported to CMS, 2019-2025
17 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $703 · 2022: $146 · 2023: $309 · 2024: $137 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $657.79 | 2021-2023 | Eterna, Eon C, Octrode |
| Medtronic, INC. | $197.62 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Boston Scientific Corporation | $187.94 | 2021-2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $142.71 | 2021-2025 | Iovera, Zilretta, Exparel |
| Biotronik Nro, INC. | $121.82 | 2025 | Prospera |
| Spinal Simplicity, LLC | $73.41 | 2024-2025 | Ha Minuteman G3-R |
| Azurity Pharmaceuticals, INC. | $53.49 | 2023-2024 | Horizant, Horizant |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.35 | 2024-2025 | Relistor |
| Almatica Pharma LLC | $49.90 | 2021-2022 | |
| Ibsa Pharma INC. | $40.60 | 2021 | |
| Globus Medical, INC. | $34.97 | 2025 | Senza |
| Saluda Medical Americas, INC. | $25.39 | 2025 | Evoke |
| Grt US Holding, INC. | $23.96 | 2022 | |
| Redhill Biopharma INC. | $21.64 | 2021 | |
| Nevro Corp. | $19.64 | 2023 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $15.97 | 2023 | Movantik |
| Arbor Pharmaceuticals, INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.